2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Allergic Reaction: new trials by email Literature Review of Allergic Reaction trials Research Report on Allergic Reaction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome DESF, Epinephrine Injection - Allergic Reaction | Phase 2 | Completed | Aquestive Therapeutics | 36 | 2024-07-17 | 2025-09-26 |
| COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19 Vaccine, Placebo - SARS-CoV Infection, COVID-19 | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 746 | 2021-04-07 | 2025-08-12 |
Hypersensitivity (2) · COVID-19 (1) · Mastocytosis (1) · Severe Acute Respiratory Syndrome (1)
Immune System Diseases (2) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Mast Cell Activation Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1)
2019-nCoV Vaccine mRNA-1273 (1) · BNT162 Vaccine (1) · Epinephrine (1) · Sodium Chloride (1)
Aquestive Therapeutics (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2)
Frank Lee, MD (1) · James R. Baker Jr., MD (1) · N. Franklin Atkinson Jr., MD (1) · Rebecca S. Gruchalla, MD, PhD (1)